Zincy 
In Vino Veritas
These vaccines were not "rushed", at least not as rushed as people think.
A lot of the slowdown in drug manufacturing comes from three sources. Red tape, marketing, and apathy.
Firstly, red tape. Drug manufacturers have to jump through a lot of hoops to get their drug to market. While a good portion of that is needed for safety, the generally overburdened FDA moves at a snail's pace. The byzantine nature of the government bureaucracy doesn't help.
Next is marketing. Huge segments of the dev process is dedicated to market research, exploring everything from entry, to competition, to partents, to advertising.
Lastly is apathy. Companies move slowly because, generally speaking, it's cheaper. There is not a pressing need (to them) to rush forward.
Covid changed the game. A lot of red tape was eliminated, and the safety inspections were granted priority. That aforementioned byzantine apparatus, while slow to rouse, can throw considerable resources at something once its awake. There was also no need to think about marketing. "We can save the world" is a pretty good marketing strategy. That, and patent waivers really put the nail in that coffin. And to say there was a pressing need to move swiftly is an understatement.
When you add these factors up, a lot of the normal dev time has nothing to do with the drug itself.
While these vaccines still moved faster even than that can explain, it was hardly "rushed".
As for the problems cropping up, that was inevitable. You're vaccinating a few billion people. Every manner of side effect and anomalous reactions will crop up. These are normal with all drugs. It's just that normally these drugs arent in the national news 24/7 and being administered to over a billion people.
A lot of the slowdown in drug manufacturing comes from three sources. Red tape, marketing, and apathy.
Firstly, red tape. Drug manufacturers have to jump through a lot of hoops to get their drug to market. While a good portion of that is needed for safety, the generally overburdened FDA moves at a snail's pace. The byzantine nature of the government bureaucracy doesn't help.
Next is marketing. Huge segments of the dev process is dedicated to market research, exploring everything from entry, to competition, to pa
Lastly is apathy. Companies move slowly because, generally speaking, it's cheaper. There is not a pressing need (to them) to rush forward.
Covid changed the game. A lot of red tape was eliminated, and the safety inspections were granted priority. That aforementioned byzantine apparatus, while slow to rouse, can throw considerable resources at something once its awake. There was also no need to think about marketing. "We can save the world" is a pretty good marketing strategy. That, and patent waivers really put the nail in that coffin. And to say there was a pressing need to move swiftly is an understatement.
When you add these factors up, a lot of the normal dev time has nothing to do with the drug itself.
While these vaccines still moved faster even than that can explain, it was hardly "rushed".
As for the problems cropping up, that was inevitable. You're vaccinating a few billion people. Every manner of side effect and anomalous reactions will crop up. These are normal with all drugs. It's just that normally these drugs arent in the national news 24/7 and being administered to over a billion people.